EUVIMEDEUVIMED entdecken
Crossref

IGF2BP3-TRIM37-P53 axis promotes tumor progression in LUAD

Ting Ji, Tingting Zhao, Shuni Wang, Xiaotong Guo, Ting Wang, Hai Tan, Shaojin Wang, Ma Gang, Juan Chen

Cellular Signalling · 2026-07 · 143 · 112480

DOI: 10.1016/j.cellsig.2026.112480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026-07. Verfasst von Ting Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ningxia Key Laboratory of Clinical and Pathogenic Microorganisms, Institute of Medical Science, General Hospital of Ningxia Medical University, Yinch…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, RNA-Binding Proteins, Tripartite Motif Proteins, Lung Neoplasms. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Ningxia Province, Ningxia Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND m6A and ubiquitination modifications critically drive lung adenocarcinoma (LUAD) progression and are closely linked to cellular context-such as p53 status. Thus, elucidating how these modifications regulate p53's role in LUAD pathogenesis is vital for targeted therapy. METHODS TCGA was used to screen for IGF2BP3, a key m6A regulator in LUAD, and its survival and differential expression were evaluated. Colony formation and CCK8 assays were used to assess the effects of IGF2BP3 on cell proliferation. TRIM37 was identified as a downstream target of IGF2BP3 using the Gene Expression Omnibus (GEO) database for bioinformatics analysis. RIP-qPCR experiments confirmed m6a enrichment of TRIM37 mRNA by IGF2BP3. The pro-tumor effects of IGF2BP3 were validated both in vivo and in vitro. RESULTS IGF2BP3 was highly expressed in lung adenocarcinoma (LUAD) and associated with poor patient prognosis. IGF2BP3 recognizes the m6A modification site in the 3'UTR of TRIM37 mRNA, stabilizing its expression. TRIM37 promotes p53 protein degradation through ubiquitination. Silencing TRIM37 reversed IGF2BP3-driven LUAD progression in vivo and in vitro. CONCLUSION Here, we found that IGF2BP3, acting as an m6A reader, promotes LUAD cell proliferation both in vivo and in vitro. Mechanistically, IGF2BP3 mediates the ubiquitination and degradation of p53 by reading the m6A-modified TRIM37 mRNA 3'UTR, thereby promoting tumorigenesis in LUAD. Importantly, shTRIM37 significantly inhibited IGF2BP3-driven tumor progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53RNA-Binding ProteinsTripartite Motif ProteinsLung NeoplasmsUbiquitin-Protein LigasesAdenocarcinoma of LungHumansAnimalsDisease ProgressionCell Line, TumorCell ProliferationUbiquitinationMiceGene Expression Regulation, NeoplasticMice, NudeRNA Methylation

Stichwörter der Autor:innen

IGF2BP3LUADTRIM37m6A modificationp53

Substanzen

Tumor Suppressor Protein p53RNA-Binding ProteinsTripartite Motif ProteinsIGF2BP3 protein, humanUbiquitin-Protein LigasesTRIM37 protein, humanTP53 protein, human

Autor:innen und Institutionen

  • Ningxia Key Laboratory of Clinical and Pathogenic Microorganisms, Institute of Medical Science, General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia, China; Department of Respiratory and Critical Car…
  • Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia, China.
  • Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia, China. Electronic address: wangshaojin1979@163.com.
  • Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia, China. Electronic address: magangonco@163.com.

Förderung

  • Natural Science Foundation of Ningxia Province
  • Ningxia Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Ji, T., Zhao, T., Wang, S., Guo, X., Wang, T., Tan, H., Wang, S., Gang, M., & Chen, J. (2026). IGF2BP3-TRIM37-P53 axis promotes tumor progression in LUAD. Cellular Signalling, 143, 112480. https://doi.org/10.1016/j.cellsig.2026.112480

Vancouver

Ji T, Zhao T, Wang S, Guo X, Wang T, Tan H, et al. IGF2BP3-TRIM37-P53 axis promotes tumor progression in LUAD. Cellular Signalling. 2026;143:112480. doi:10.1016/j.cellsig.2026.112480

BibTeX
@article{Ji2026,
  author = {Ji, Ting and Zhao, Tingting and Wang, Shuni and Guo, Xiaotong and Wang, Ting and Tan, Hai and Wang, Shaojin and Gang, Ma and Chen, Juan},
  title = {IGF2BP3-TRIM37-P53 axis promotes tumor progression in LUAD},
  journal = {Cellular Signalling},
  year = {2026},
  volume = {143},
  pages = {112480},
  doi = {10.1016/j.cellsig.2026.112480}
}
Kostenlos starten →